L'Oréal's recent portfolio expansion: the August 2023 Aesop acquisition at $2.587 billion (largest in company history) and the late-2022 Skinbetter Science purchase
L'Oréal SA (EPA: OR), the global beauty conglomerate founded by Eugène Schueller in 1909, made two of its largest acquisitions in recent years to extend its prestige and active-cosmetics portfolios. The Aesop acquisition was the company's most expensive ever: announced on April 3, 2023 and completed on August 30, 2023, at a final purchase price of $2,586,988,081 (approximately $2.587 billion). Aesop, the Australian-founded skincare and personal-care brand previously owned by Brazil's Natura & Co., joined L'Oréal's luxury division alongside Lancôme, Yves Saint Laurent, and Kiehl's. Earlier, in September 2022, L'Oréal had signed an agreement to acquire Skinbetter Science, a physician-dispensed American skincare brand based in Arizona, with deal-completion expected in early Q4 2022. Skinbetter Science had generated approximately $95 million in sales in the twelve months to August 31, 2022. Skinbetter Science joined L'Oréal USA's Active Cosmetics Division under Christina Fair.
- Story: L'Oréal SA (EPA: OR), the global beauty conglomerate founded by Eugène Schueller in 1909, made two of its largest acquisitions in recent years. The Aesop acquisition was the company's most expensive ever: announced April 3, 2023 and completed August 30, 2023 at a final purchase price of $2,586,988,081 (~$2.587 billion). Aesop joined L'Oréal's Luxe division alongside Lancôme, Yves Saint Laurent, and Kiehl's. Earlier, in September 2022, L'Oréal had signed to acquire Skinbetter Science — a physician-dispensed American skincare brand — with closing expected in early Q4 2022.
- Why it matters: Both acquisitions fill specific portfolio gaps. Aesop occupies prestige-artisanal-skincare positioning where L'Oréal's mass-luxury brands like Lancôme don't fully cover. Skinbetter occupies the physician-dispensed channel — sold primarily through dermatologists, plastic surgeons, and medical aesthetic practices — which is structurally distinct from retail-channel beauty.
- Takeaway: Skinbetter Science had generated approximately $95 million in sales in the twelve months to August 31, 2022.
- Takeaway: Skinbetter was co-founded in 2016 by Jonah Shacknai (also the founder of Medicis Pharmaceutical), Justin Smith, and Seth Rodner.
- Takeaway: Natura & Co was the seller of Aesop. Natura had acquired Aesop in 2013 for ~$60M; the 2023 sale at ~$2.587B reflected substantial brand-equity development under Natura ownership.
L'Oréal's portfolio strategy
L'Oréal's recent acquisitions
Quick facts
The Aesop acquisition: April 2023 agreement, August 30, 2023 close, $2.587B price
On April 3, 2023, L'Oréal announced an agreement to acquire Aesop from Brazilian group Natura & Co. The transaction closed on August 30, 2023 at a final purchase price of $2,586,988,081 — approximately $2.587 billion. L'Oréal characterized it as the largest acquisition in the company's history at that point. Aesop, founded in Melbourne, Australia in 1987 by Dennis Paphitis, had grown into a global prestige skincare and personal-care brand known for distinctive minimalist packaging, retail-store design, and a focus on plant-based formulations. The brand joined L'Oréal's Luxe Division — the same division as Lancôme, Yves Saint Laurent, and Kiehl's. Aesop's positioning extends L'Oréal's reach into an artisanal/independent luxury aesthetic that complements rather than replaces the existing prestige portfolio.
Skinbetter Science: physician-dispensed skincare in the Active Cosmetics Division
In September 2022, L'Oréal announced an agreement to acquire Skinbetter Science, a Scottsdale, Arizona-based physician-dispensed skincare brand co-founded in 2016 by Jonah Shacknai (also the founder of Medicis Pharmaceutical), Justin Smith, and Seth Rodner. Skinbetter sells its products primarily through dermatologists, plastic surgeons, and medical aesthetic practices — a 'doctor-channel' distribution model that is structurally distinct from retail-channel beauty. The brand had generated approximately $95 million in sales in the twelve months to August 31, 2022. Closing was expected in early Q4 2022, subject to regulatory approvals. Skinbetter Science joined L'Oréal USA's Active Cosmetics Division under division president Christina Fair, complementing L'Oréal's existing professional dermatology brands (La Roche-Posay, Vichy, CeraVe, others).
Strategic logic: extending the L'Oréal portfolio into doctor-channel and prestige-artisanal
The two acquisitions taken together — Aesop into Luxe, Skinbetter into Active Cosmetics — extend L'Oréal's portfolio into segments that L'Oréal's existing brand-portfolio did not fully address. Aesop occupies the prestige-artisanal-skincare segment where mass-luxury (Lancôme, Yves Saint Laurent) doesn't fully compete; Aesop's specific brand positioning — minimalist, plant-based, retail-design-led — is complementary rather than substitutive. Skinbetter occupies the physician-dispensed channel, where the customer relationship is mediated by medical professionals rather than retail clerks or e-commerce. That channel is structurally important for active-cosmetics products that benefit from medical-professional endorsement. Together the acquisitions are an example of L'Oréal's serial-M&A strategy: buy distinctive brands that strengthen specific portfolio gaps rather than consolidating direct competitors.
L'Oréal's broader portfolio context
L'Oréal operates across four divisions: Luxe (which now includes Aesop, Lancôme, Yves Saint Laurent, Kiehl's, Helena Rubinstein, Urban Decay, NYX Professional Makeup, IT Cosmetics, Maison Margiela Fragrance, Atelier Cologne, Mugler, Prada Beauty, Valentino Beauty, Polo Ralph Lauren Fragrances, Giorgio Armani Beauty, and others); Consumer Products (L'Oréal Paris, Maybelline, Garnier, NYX in mass retail); Active Cosmetics (CeraVe, La Roche-Posay, Vichy, Skinbetter Science, SkinCeuticals); and Professional Products (Kérastase, L'Oréal Professionnel, Redken). The serial-M&A pattern has been consistent: identify a category gap, find a distinctive brand that fills it, integrate it under the relevant division. L'Oréal's history of doing this successfully across multiple acquisitions over the past decade is why the company has remained the largest pure-play beauty company in the world by revenue.
Frequently asked questions
How much did L'Oréal pay for Aesop?
The final purchase price was $2,586,988,081 — approximately $2.587 billion. L'Oréal completed the acquisition on August 30, 2023, having announced the agreement on April 3, 2023. The price made Aesop the most expensive acquisition in L'Oréal's history at the time.
Who sold Aesop to L'Oréal?
Natura & Co, the Brazilian beauty group. Aesop had been part of Natura's portfolio (alongside Avon and The Body Shop, both subsequently divested). Natura had originally acquired Aesop in 2013. The 2023 sale was part of Natura's strategic refocus toward its core Brazilian and Latin American beauty businesses.
When did L'Oréal buy Skinbetter Science?
L'Oréal announced the agreement in September 2022. The expected closing was early Q4 2022, subject to regulatory approvals. Skinbetter Science is now part of L'Oréal USA's Active Cosmetics Division under division president Christina Fair.
How does Skinbetter's distribution model work?
Skinbetter Science is physician-dispensed — its products are sold primarily through a network of dermatologists, plastic surgeons, and medical aesthetic practices, rather than at department-store counters or pharmacies. The model relies on a dedicated medical sales force to support professional adoption. It's a structurally different go-to-market than mass-retail or DTC beauty, and adoption depends on medical-professional endorsement of formulations.
What's the strategic logic of these acquisitions?
Both fill specific portfolio gaps. Aesop extends L'Oréal Luxe into prestige-artisanal positioning (minimalist, plant-based, retail-design-led) that L'Oréal's mass-luxury brands like Lancôme don't fully cover. Skinbetter extends L'Oréal Active Cosmetics into the physician-dispensed channel — a structurally important segment for medical-grade actives where professional endorsement matters. Together they continue L'Oréal's serial-M&A strategy of buying distinctive brands that strengthen specific gaps rather than consolidating direct competitors.
Sources & references
- L'Oréal completes acquisition of Aesop (L'Oréal press release, August 30, 2023) — Primary source for the Aesop acquisition close and final purchase price.
- L'Oréal completes acquisition of Aesop (BW Confidential) — Trade press coverage of the August 2023 deal close.
- L'Oréal Acquires Aesop for $2.58 Billion (Beauty Packaging) — Industry coverage of the Aesop acquisition with the dollar value.
- L'Oréal signs an agreement to acquire Skinbetter Science (L'Oréal Finance) — L'Oréal's primary press release announcing the September 2022 Skinbetter Science agreement.
- L'Oréal to Acquire Physician-Dispensed Skinbetter Science (BeautyMatter) — Industry coverage with detail on Skinbetter's distribution model and L'Oréal integration plans.